Drug Discovery Unit
The University of Dundee’s contribution to a major Covid-testing facility has been recognised at the 6th Scottish Knowledge Exchange Awards.
The COVID-19 Collaborative Response Award was made to the Lighthouse Laboratory in Glasgow, hosted by University of Glasgow at the Queen Elizabeth University Hospital Campus, a major new COVID-19 testing facility established with BioAscent Ltd and the University of Dundee, and subsequently developed and managed by the University of Glasgow in collaboration with high-throughput industry experts BioClavis Ltd.
The Drug Discovery Unit (DDU) (http://www.drugdiscovery.dundee.ac.uk) is a fully integrated drug discovery operation based within a world class Life Sciences research environment. It is a dynamic and multidisciplinary group of 95 scientists with expertise in compound handling, assay development, high-throughput screening, medicinal and computational chemistry and in vitro and in vivo pharmacokinetics. The unit is housed in a state-of-the-art building and has cutting-edge equipment and automation for hit-discovery and lead optimisation.
The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.
The impact that an ageing population has on the health and wellbeing of individuals, groups, communities and societies, and what we can do to address these challenges, will be the focus of a University of Dundee lecture.
A host of fun activities aimed at promoting STEM subjects to girls and young women launches in Dundee today.
As part of Dundee Women’s Festival (Friday 5 to Sunday 14 March 2021) and International Women’s Day (Monday 8 March 2021), Dundee Science Centre is teaming up with women scientists at the University of Dundee to promote STEM subjects to younger children.
The Drug Discovery Unit (DDU) is passionate about tackling unmet medical need for globally important neglected and emerging infectious diseases (including TB, malaria, Chagas disease, coronaviruses), that kill millions of people across the world every year and damage the economies of many low- and middle-income countries.
A post has become available for a highly motivated Enzymologist / Biochemist to join the Drug Discovery Unit (DDU, www.drugdiscovery.dundee.ac.uk/) and Wellcome Centre for Anti-Infectives Research (WCAIR, https://wcair.dundee.ac.uk/), University of Dundee. WCAIR supports and works closely with the DDU to facilitate the discovery and development of new drugs for neglected infectious tropical diseases.
The Drug Discovery Unit (DDU), University of Dundee is seeking a highly motivated and expert medicinal chemist to lead the DDU’s coronavirus drug discovery programme to deliver novel broad-spectrum anti-coronavirus drugs.
Ingo Hein, Jens Januschke, Steve Land, Beatriz Baragana, Sheriar Hormuzdi and Susan Wyllie promoted as part of the 2020 Annual Review process for academic staff.
Inke Nathke, Interim Dean of School said, “I am delighted to congratulate Ingo Hein, Jens Januschke and Stephen Land on their promotions to Reader, Sheriar Hormuzdi to Senior Lecturer and also Beatriz Baragana and Susan Wyllie. It is a fitting acknowledgment of their outstanding contributions to research and teaching and I am proud to have such accomplished colleagues in our School.”